Synergistic effect of the combination triclosan with 2-phenylphenol against Pseudomonas aeruginosa and fungi

Saudi Medical Journal

Volumn 26, Issue 5, 2005, Pages 723-727

  Tumah, Haitham N ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBIPHENYL; TRICLOSAN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; DILUTION; DRUG POTENTIATION; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; JORDAN; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; UNIVERSITY;

ANTI-INFECTIVE AGENTS, LOCAL; BIPHENYL COMPOUNDS; DRUG SYNERGISM; FUNGI; FUNGICIDES, INDUSTRIAL; PSEUDOMONAS AERUGINOSA; TRICLOSAN;

EID: 21344432823     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. McDonnell G, Russell AD. Antiseptics and disinfectants: active, action and resistance. Clin Microbiol Rev 1999; 12: 147-179.
2. Arweiler NB, Netuschil L, Reich E. Alcohol-free mouthrinse solutions to reduce supragingival plaque regrowth and vitality. J Clin Periodontol 2001; 28: 168-174.
3. Gaffar A, Afflitto J, Nabi N, Kruger I, Olsen S. Recent advances in plaque, gingivitis, and tartar and caries prevention technology. Int Dent J 1994; 44: 63-70.
4. Herbert PS. Triclosan a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 2001; 202: 1-7.
5. Marchetti MG, Kampf G, Finzi G, Salvatorelli G. Evaluation of the bactericidal effect of five products for surgical hand disinfection according to prEN 12054 and prEN 12791. J Hosp Infect 2003; 54: 63-67.
6. Bending JWA. Surgical hand disinfection: Comparison of 4% chlorhexidine detergent solution and 2% triclosan detergent solution. J Hosp Infect 1990; 15: 143-148.
7. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995; 23: 251-269.
8. Webster J. Handwashing in neonatal intensive care nursery: product acceptability and effectiveness of chlorhexidine gluconate 4% and triclosan 1%. J Hosp Infect 1992; 2: 137-141.
9. Heath JH, Holland DR, Zhang E, Snow ME, Rock CO. Mechanism of triclosan of bacterial fatty acid synthesis. J Biol Chem 1999; 274: 11110-11114.
10. Josephine J, Martin CJ. The antibacterial activity of triclosan-impregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus and Shewanella putrefaciens in conditions simulating domestic use. J Antimicrob Chemother 2002; 49: 87-94.
11. Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Clayton E. Molecular basis of triclosan activity. Nature 1999; 398: 383-384.
12. Ward WHJ, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton, E. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry 1999; 38: 12514-12525.
13. Chuanchuen R, Beinlich K, Hoang TT, Becher A, RoxAnn R, Karkhoff-Schweizer RR, et al. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a Susceptible mutant strain to triclosan selects nfxB mutants over-expressing MexCD-Opr. J Antimicrob Chemother 2001; 45: 428-432.
14. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998; 94: 531-532.
15. Seymour SB. Disinfectant, Sterilization, and Preservation, 5nd edn. Philadelphia (PA): Lippincott Williams & Wilkins; 2001.
16. Lueck E. Antimicrobial Food Additives. Berlin: Springer-Verlag; 1980.
17. Hernandez A, Martro E, Matas L, Martin M, Ausine V. Assessment of in-vitro efficacy of 1% Virkon against bacteria, fungi, viruses, and spores by means of AFNOR guidelines. J Hosp Infect 2000; 46: 203-209.
18. Russell AD, Hugo WB, Aylffe GAJ. Disinfection, Preservation and Sterilization. 3rd ed. Oxford: Blackwell Science; 1999.
19. Bruhn G, Netuschil L, Richter ST, Brecx M, Hoffmann T. Effect of a toothpaste containing triclosan on dental plaque, gingivitis, and bleeding on probing-an investigation in periodontitis patients over 28 weeks. Clin Oral Investig 2002; 6: 124-127.
20. Faogali J, Fong J, Georg N, Mahoney P, O'Rourke V. Comparison of the immediate, residual, and cumulative antibacterial effects of Noraderm, Novascrub R, Betadine Surgical Scrub, Hibiclens, and liquid soap. Am J Infect Control 1995; 23: 337-343.
21. Healy CM, Cruchley AT, Thornhill MH, Williams DM. The effect of sodium lauryl sulphate, triclosan and zinc on the permeability of normal oral mucosa. Oral Dis 2000; 6: 118-123.
22. Nogueira-Filho GR, Toledo S, Cury JA. Effect of three dentifrices containing triclosan and various additives. An experimental gingivitis study. J Clin Periodontol 2000; 27: 494-498.
23. Hugo WB, Russell AD. Pharmaceutical Microbiology. 5th ed. Oxford: Blackwell Scientific; 1998.
24. Heath RJ, Rock CO. A Triclosan-resistant bacterial enzyme. Nature 2000; 406: 145.
25. Chuanchen R, Karkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control 2003; 31: 124-127.
26. Webster J, Faogali JL, Cartwright D. Elimination of methicillin-resistant staphylococcus aureus from a neonatal intensive care unit after handwashing with triclosan. J Paediatr Child Health 1994; 30: 59-64.
27. Suller MTE, Russell AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 11-18.
28. Marcia AG, Antia T, Marly PN, Katia RN. Disinfectants and antibiotic activities: A comparative analysis in Brazilian hospital bacterial isolates. Brazilian Journal of Microbiology 2000; 31: 193-199.